NL-OMON35250已完成不适用
Open-label phase I study to investigate the effect of multiple doses of tasquinimod on the single-dose pharmacodynamics and pharmacokinetics of warfarin in healthy subjects - Tasquinimod - Warfarin Interaction Study
Active Biotech0 个研究点目标入组 15 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •healthy male and female volunteers
- •age: 18-55 years, inclusive
- •BMI: 18.0-30.0 kg/m2, inclusive
排除标准
- •- Suffering from hepatitis B, cancer or HIV/AIDS
- •- In case of participation in another drug study within 60 days before the start of this study
- •- In case of donation of more than 50 ml of blood within 60 days prior to drug administration
- •- Donation of more than 1.5 L of blood (for men) / more than 1.0 L of blood (for women) in the 10 months preceding the start of the study
研究者
相似试验
已完成
1 期
A phase 1 open-label study evaluating the effects of food on TAS-205 in healthy volunteersDuchenne Muscular DystrophyJPRN-jRCT2071230028Takeda Shin'ichi20
尚未招募
不适用
An open-label, Phase I study to assess the effect of itraconazole (CYP3A4 and P-gp inhibitor) on the pharmacokinetics of anetumab ravtansine and to assess the ECG effects, safety and immunogenicity of anetumab ravtansine given as a single agent and together with itraconazole in subjects with mesothelin-expressing advanced solid cancers.eoplasmata, maligne en niet-gespecificeerd: lokaal gevorderde of metastatische solide kankersoorten met mesotheline-expressie.Mesothelin-expressing advanced solid cancersNL-OMON46366Bayer8
已完成
不适用
A Phase I, Open-Label Study to Determine the Effect of Repeat Dosing of Trametinib on the Pharmacokinetics of a Combined Oral Contraceptive (Norethindrone plus Ethinyl Estradiol) in Female Patients with Solid TumorsSolid tumorsSolid tumors with a BRAF V600 mutation10027655NL-OMON47513ovartis2
已完成
不适用
An Open-Label Phase I Study to Assess the Effect of Rifampicin in the Pharmacokinetics of Eribulin Mesylate (E7389) in Subjects with Advanced Solid Tumoursdrug metabolism / cancer10027656NL-OMON32968Eisai14
进行中（未招募）
1 期
A study to determine if GBT440 can increase the level of oxygen in the blood of people with Idiopathic Pulmonary Fibrosis (IPF) who need to use supplemental oxygen when resting.Idiopathic Pulmonary Fibrosis (IPF)MedDRA version: 20.0 Level: PT Classification code 10021240 Term: Idiopathic pulmonary fibrosis System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2017-001276-27-GBGlobal Blood Therapeutics Inc.32